Evaluating and improving biocompatibility of conductive polymers for cardiac tissue engineering

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cardiovascular Engineering

Background:

• Conductive polymers (CPs) are increasingly explored for cardiac tissue engineering (CTE) due to their electrical properties.
• Challenges persist, including biocompatibility issues, dopant toxicity, and long-term stability, hindering clinical translation.
• Key CPs like polypyrrole (PPy), poly(3,4-ethylenedioxythiophene) (PEDOT), and polyaniline (PANI) require thorough safety evaluation.

Purpose of the Study:

• To review the properties, applications, and biocompatibility of PPy, PEDOT, and PANI in CTE.
• To critically assess current biocompatibility testing methods and identify limitations.
• To propose a standardized framework for evaluating CP biocompatibility and guide future research.

Main Methods:

• Literature review of PPy, PEDOT, and PANI in CTE.
• Comparative analysis of CPs against inorganic and carbon-based materials.
• Assessment of traditional in vitro and in vivo biocompatibility testing limitations.
• Identification of data gaps, particularly in chronic implantation studies (>6 months).

Main Results:

• Significant gaps exist in chronic implantation data and standardized biocompatibility assessments for CPs.
• Dopant-dependent cytotoxicity and long-term stability remain critical concerns.
• Current testing methods have limitations in predicting real-world performance and safety.

Conclusions:

• A standardized roadmap for CP biocompatibility evaluation is proposed, incorporating advanced in vitro models (3D heart tissues, organoids) and in vivo studies.
• Strategies like hybrid scaffolds and molecular engineering can enhance CP biocompatibility.
• Addressing regulatory requirements and establishing standardized testing are crucial for advancing CPs in cardiac tissue engineering.